Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 12, 2016, Pages 2250-2255

  Greco, Raffaella ^a   Crucitti, Lara ^b   Noviello, Maddalena ^a   Racca, Sara ^a   Mannina, Daniele ^a   Forcina, Alessandra ^a   Lorentino, Francesca ^a   Valtolina, Veronica ^a   Rolla, Serena ^a   Dvir, Roee ^a   Morelli, Mara ^a   Giglio, Fabio ^a   Barbanti, Maria Chiara ^a   Lupo Stanghellini, Maria Teresa ^a   Oltolini, Chiara ^a   Vago, Luca ^a   Scarpellini, Paolo ^a   Assanelli, Andrea ^a   Carrabba, Matteo G ^a   Marktel, Sarah ^a   Bernardi, Massimo ^a   Corti, Consuelo ^a   Clementi, Massimo ^a,c   Peccatori, Jacopo ^a   Bonini, Chiara ^a   Ciceri, Fabio ^a,c   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Human herpesvirus 6; T cell immune reconstitution

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR; ANTIVIRUS AGENT; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CD3 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CLINICAL FEATURE; CLINICAL OUTCOME; CYTOMEGALOVIRUS; DIARRHEA; ENCEPHALITIS; ENGRAFTMENT; FEMALE; FEVER; GENETIC SCREENING; GRAFT FAILURE; GRAFT RECIPIENT; GUT BIOPSY; HAPLOIDENTICAL TRANSPLANTATION; HEPATITIS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; LIVER BIOPSY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOID LEUKEMIA; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RASH; RELAPSE; REMISSION; RETROSPECTIVE STUDY; TRANSPLANTATION; VIRUS LOAD; VIRUS REACTIVATION; EXANTHEMA SUBITUM; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LYMPHOCYTE COUNT; MIDDLE AGED; MORTALITY; PHYSIOLOGY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIROLOGY; VIRUS ACTIVATION; VIRUS INFECTION; YOUNG ADULT;

ADULT; AGED; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; EXANTHEMA SUBITUM; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; STEROIDS; SURVIVAL ANALYSIS; TRANSPLANTATION, HAPLOIDENTICAL; TREATMENT OUTCOME; VIRUS ACTIVATION; VIRUS DISEASES; YOUNG ADULT;

EID: 85002665910     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2016.09.018     Document Type: Article

References (38)

1. 1 Ljungman, P., de la Camara, R., Cordonnier, C., et al. Management of CMV, HHV-6, HHV-7 and Kaposi sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 42 (2008), 227–240.
2. 2 Briggs, M., Fox, J., Tedder, R.S., Age prevalence of antibody to human herpesvirus 6. Lancet 1 (1988), 1058–1059.
3. 3 Okuno, T., Takahashi, K., Balachandra, K., et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 27 (1989), 651–653.
4. 4 Zerr, D.M., Meier, A.S., Selke, S.S., et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352 (2005), 768–776.
5. 5 Kondo, K., Kondo, T., Okuno, T., et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 72:Pt 6 (1991), 1401–1408.
6. 6 Ruell, J., Barnes, C., Mutton, K., et al. Active CMV disease does not always correlate with viral load detection. Bone Marrow Transplant 40 (2007), 55–61.
7. 7 De Bolle, L., Naesens, L., De Clercq, E., Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18 (2005), 217–245.
8. 8 Cone, R.W., Huang, M.L., Ashley, R., Corey, L., Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol 31 (1993), 1262–1267.
9. 9 Zerr, D.M., Corey, L., Kim, H.W., et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40 (2005), 932–940.
10. 10 Yoshikawa, T., Suga, S., Asano, Y., et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 78 (1991), 1381–1384.
11. 11 Clark, D.A., Griffiths, P.D., Human herpesvirus 6: relevance of infection in the immunocompromised host. Br J Haematol 120 (2003), 384–395.
12. 12 Zerr, D.M., Human herpesvirus 6 (HHV-6) disease in the setting of transplantation. Curr Opin Infect Dis 25 (2012), 438–444.
13. 13 Ljungman, P., Wang, F.Z., Clark, D.A., et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 111 (2000), 774–781.
14. 14 Cone, R.W., Hackman, R.C., Huang, M.L., et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329 (1993), 156–161.
15. 15 Kadakia, M.P., Rybka, W.B., Stewart, J.A., et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 87 (1996), 5341–5354.
16. 16 Cone, R.W., Huang, M.L., Corey, L., et al. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 179 (1999), 311–318.
17. 17 Drobyski, W.R., Dunne, W.M., Burd, E.M., et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 167 (1993), 735–739.
18. 18 Zerr, D.M., Gooley, T.A., Yeung, L., et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33 (2001), 763–771.
19. 19 de Pagter, P.J., Schuurman, R., Meijer, E., et al. Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. J Clin Virol 43 (2008), 361–366.
20. 20 Potenza, L., Barozzi, P., Masetti, M., et al. Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients. Am J Transplant 9 (2009), 1690–1697.
21. 21 Pellett, P.E., Ablashi, D.V., Ambros, P.F., et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 22 (2012), 144–155.
22. 22 Dulery, R., Salleron, J., Dewilde, A., et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. Biol Blood Marrow Transplant 18 (2012), 1080–1089.
23. 23 Yoshikawa, T., Asano, Y., Ihira, M., et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 185 (2002), 847–853.
24. 24 Peccatori, J., Forcina, A., Clerici, D., et al. Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors. Leukemia 29 (2015), 396–405.
25. 25 Cieri, N., Greco, R., Crucitti, L., et al. Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells. Biol Blood Marrow Transplant 21 (2015), 1506–1514.
26. 26 Ogata, M., Kikuchi, H., Satou, T., et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 193 (2006), 68–79.
27. 27 Hentrich, M., Oruzio, D., Jäger, G., et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 128 (2005), 66–72.
28. 28 Gratama, J.W., Zwaan, F.E., Stijnen, T., et al. Herpesvirus immunity and acute graft-versus-host disease. Lancet 1 (1987), 471–474.
29. 29 Grivel, J.C., Santoro, F., Chen, S., et al. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J Virol 77 (2003), 8280–8289.
30. 30 Tang, H., Serada, S., Kawabata, A., et al. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A 110 (2013), 9096–9099.
31. 31 Ge, X., Brown, J., Sykes, M., Boussiotis, V.A., CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors. Biol Blood Marrow Transplant 14 (2008), 518–530.
32. 32 Verhoeven, D.H., Claas, E.C., Jol-van der Zijde, C.M., et al. Reactivation of human herpesvirus 6 after pediatric stem cell transplantation: risk factors, onset, clinical symptoms and association with severity of acute graft-versus-host disease. Pediatr Infect Dis J 34 (2015), 1118–1127.
33. 33 Ljungman, P., Immune reconstitution and viral infections after stem cell transplantation. Bone Marrow Transplant 21:Suppl 2 (1998), S72–74.
34. 34 Noviello, M., Forcina, A., Veronica, V., et al. Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall. Bone Marrow Transplant 50 (2015), 1262–1264.
35. + T cell response to human herpesvirus 6. J Virol 86 (2012), 4776–4792.
36. + T-cell subsets. J Virol 83 (2009), 5442–5450.
37. 37 de Pagter, A.P., Boelens, J.J., Scherrenburg, J., et al. First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV-6 reactivation in stem cell transplantation recipients. Clin Immunol 144 (2012), 179–189.
38. 38 Greco, R., Oliveira, G., Stanghellini, M.T., et al. Improving the safety of cell therapy with the TK-suicide gene. Front Pharmacol, 6, 2015, 95.